Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
Status:
Recruiting
Trial end date:
2024-01-31
Target enrollment:
Participant gender:
Summary
The purpose of this research is to understand whether the drug metformin could be used in the
future to help prevent patients with monoclonal gammopathy of undetermined significance
(MGUS) and smoldering multiple myeloma (SMM) from developing multiple myeloma.
The names of the study drug involved in this study is:
- Metformin, extended release
- Placebo ( a pill that has no active ingredients)